Cargando…
22511 Glycolipid-loaded nanoparticles harness iNKT cells for tumor immunotherapy
ABSTRACT IMPACT: My work is on the development of a novel tumor immunotherapy to treat various types of cancer OBJECTIVES/GOALS: As iNKT cells can have direct and indirect killing effects on tumor cells, we propose a novel strategy for activating iNKT cells, via a PLGA nanoparticle delivery platform...
Autores principales: | Shute, Travis, Dudley, Elizabeth, Lai, Andrew, Salas, Briana, Vincent, Brandy, Angel, Daniel, Nash, Kelly, Leadbetter, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827700/ http://dx.doi.org/10.1017/cts.2021.406 |
Ejemplares similares
-
RIPK1 deficiency prevents thymic NK1.1 expression and subsequent iNKT cell development
por: Hägglöf, Thomas, et al.
Publicado: (2023) -
A Rapid Fluorescence-Based Assay for Classification of iNKT Cell Activating Glycolipids
por: Arora, Pooja, et al.
Publicado: (2011) -
Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023) -
Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020) -
iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022)